Mark G. Edwards, Director at ACELRX PHARMACEUTICALS INC (ACRX), bought 5,000 shares at $3.03 ($15K) on 2017-08-24, disclosed to the SEC on 2017-08-24.
Open-market purchase of $15k ACRX by Director. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history). Context: insider career grade D.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $2.90 | 200 | $580 | 3.8% |
| 2 | $3.03 | 4,800 | $15K | 96.2% |
| Total | $3.02 avg | 5,000 | $15K | 100% |
| Filing → |
| ACRX | BUY | 2019-03-12 | $114K | — | Filing → |
| ACRX | BUY | 2018-11-15 | $58K | — | Filing → |
| ACRX | BUY | 2018-08-08 | $15K | — | Filing → |